CFR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cullen/Frost Bankers is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 ready to invest. The stock looks fundamentally respectable and analysts have become somewhat more constructive after earnings, but the current setup is mixed: price is drifting below the prior close, technicals are only neutral-to-slightly positive, and there is no strong proprietary buy signal today. For an impatient investor, this is not the best immediate entry. I would wait rather than buy now.
CFR closed at 136.34 after a -0.53% regular-session decline from 139.01, with post-market weakness at -1.92%, so near-term momentum is soft. MACD histogram is slightly positive and expanding, which is constructive, but RSI-6 at 56.9 is neutral and moving averages are converging, indicating no clear trend breakout. The pivot is 136.868, meaning the stock finished just below a key reference point. Resistance sits near 139.50 and 141.13, while support is 134.23 and 132.61. Overall, the chart is range-bound rather than decisively bullish.
Analyst sentiment improved after earnings, with Stephens upgrading CFR to Overweight and Raymond James raising to Outperform. Several firms also raised price targets after Q1 results, citing broad-based EPS and pre-provision net revenue upside, improved NII/NIM outlook, loan growth, and credit quality. The company is viewed as a relatively defensive regional bank with solid fundamentals and an organic expansion strategy that may continue to support profitability. Option positioning is also bullish, with call activity dominating.
There was no fresh news in the past week, so there is no event-driven catalyst currently driving the stock. Citi still keeps a Sell rating, showing the Street is not uniformly bullish. The recent price action is weak versus the previous close, and the technical setup does not yet show strong upside confirmation. Insider and hedge fund trading trends are neutral, and there is no recent congress or influential-person trading signal to reinforce conviction.
A full latest-quarter financial snapshot was not provided due to data error, but the available analyst commentary indicates the latest quarter was solid. The most recent quarter referenced is Q1 2026, and it was described as an earnings beat with broad EPS and PPNR upside, slight NII guide improvement, and better outlook across NII, NIM, loan growth, and credit quality. That suggests the company’s latest quarter showed healthy growth trends and stable operating performance.
Analyst sentiment is mixed but improved recently. In early May, Stephens upgraded CFR to Overweight and raised its price target to 164, while Raymond James moved to Outperform with a 155 target. DA Davidson remained Neutral, Evercore stayed In Line, and Citi still has a Sell rating with a 131 target. Price targets generally moved up or were maintained after Q1 results, reflecting better earnings and growth expectations. Wall Street’s pros: strong earnings beat, improving loan/NII trends, defensive profile, and solid credit quality. Cons: valuation premium to peers, lingering credit uncertainty, and at least one bearish analyst still sees downside.
